{"id":"tpa","safety":{"commonSideEffects":[{"rate":"0.6–6%","effect":"Intracranial hemorrhage"},{"rate":"5–15%","effect":"Major bleeding"},{"rate":"20–30%","effect":"Minor bleeding"},{"rate":null,"effect":"Reperfusion arrhythmias"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"tPA is a serine protease that binds to fibrin in blood clots and catalyzes the conversion of plasminogen to plasmin, a potent fibrinolytic enzyme. Plasmin then degrades the fibrin matrix that holds the clot together, dissolving the thrombus and restoring perfusion. This mechanism makes tPA effective for acute thromboembolic conditions where rapid clot dissolution is critical.","oneSentence":"tPA (tissue plasminogen activator) converts plasminogen to plasmin, which breaks down fibrin clots to restore blood flow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:38:57.698Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke (within 4.5 hours of symptom onset)"},{"name":"Acute myocardial infarction"},{"name":"Pulmonary embolism"}]},"trialDetails":[{"nctId":"NCT07471256","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-31","conditions":"Intracerebral Hemorrhage Lobar","enrollment":636},{"nctId":"NCT05065216","phase":"PHASE2, PHASE3","title":"Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)","status":"RECRUITING","sponsor":"DiaMedica Therapeutics Inc","startDate":"2021-11-07","conditions":"Acute Stroke, Ischemic Stroke, Stroke","enrollment":728},{"nctId":"NCT07469293","phase":"PHASE3","title":"Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)","status":"NOT_YET_RECRUITING","sponsor":"Southwest Hospital, China","startDate":"2026-03-25","conditions":"Acute Ischemic Stroke","enrollment":488},{"nctId":"NCT07203625","phase":"PHASE4","title":"Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-20","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":316},{"nctId":"NCT07253181","phase":"PHASE3","title":"Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-06","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients","enrollment":572},{"nctId":"NCT07476898","phase":"PHASE3","title":"Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2026-03-01","conditions":"Stroke","enrollment":864},{"nctId":"NCT07361302","phase":"PHASE3","title":"A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-02-17","conditions":"Acute Ischemic Stroke","enrollment":1325},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT07471282","phase":"PHASE3","title":"Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy","status":"NOT_YET_RECRUITING","sponsor":"Chuansheng Zhao","startDate":"2026-03-01","conditions":"Stroke","enrollment":344},{"nctId":"NCT05491356","phase":"PHASE4","title":"Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2023-05-11","conditions":"Hematoma, Subdural, Fibrinolytic; Hemorrhage","enrollment":40},{"nctId":"NCT02860260","phase":"NA","title":"Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2011-02","conditions":"Ischemic Stroke","enrollment":50},{"nctId":"NCT07066020","phase":"NA","title":"Telehealth Exercise Boosts Sleep and Reduces Parental Stress in Autism","status":"COMPLETED","sponsor":"Hunan Normal University","startDate":"2022-10-01","conditions":"Autism Spectrum Disorder (ASD, Sleep Disturbances in Children, Parental Stress","enrollment":160},{"nctId":"NCT07432373","phase":"","title":"Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection","status":"NOT_YET_RECRUITING","sponsor":"National University of Malaysia","startDate":"2026-04-01","conditions":"Pleural Infection","enrollment":80},{"nctId":"NCT04667078","phase":"PHASE3","title":"REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2022-03-02","conditions":"Acute Ischemia","enrollment":368},{"nctId":"NCT06018181","phase":"","title":"Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice","status":"COMPLETED","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2023-09-28","conditions":"Ischemic Stroke, Acute","enrollment":2408},{"nctId":"NCT05903417","phase":"NA","title":"Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2023-07-10","conditions":"Pleural Infection","enrollment":40},{"nctId":"NCT06241677","phase":"NA","title":"Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-04-15","conditions":"CVA (Cerebrovascular Accident)","enrollment":260},{"nctId":"NCT05983757","phase":"NA","title":"Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe","status":"RECRUITING","sponsor":"Raul Nogueira","startDate":"2024-04-02","conditions":"Ischemic Stroke","enrollment":584},{"nctId":"NCT06427538","phase":"NA","title":"Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-06-21","conditions":"Empyema, Pleural, Pleural Infection","enrollment":96},{"nctId":"NCT07375953","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":120},{"nctId":"NCT04918719","phase":"PHASE2","title":"Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-11-02","conditions":"Acute Ischemic Stroke","enrollment":4},{"nctId":"NCT07375966","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":198},{"nctId":"NCT07419997","phase":"","title":"A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-29","conditions":"Stroke","enrollment":2600},{"nctId":"NCT05701956","phase":"PHASE3","title":"Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion","status":"COMPLETED","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2023-03-16","conditions":"Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion","enrollment":330},{"nctId":"NCT04194138","phase":"","title":"Complex Adult Deformity Surgery (CADS)","status":"RECRUITING","sponsor":"International Spine Study Group Foundation","startDate":"2018-07-30","conditions":"Adult Spinal Deformity, Scoliosis, Kyphosis","enrollment":1500},{"nctId":"NCT07411079","phase":"","title":"Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Intracerebral Hemorrhage, Hemorrhagic Risk Conditions, Bleeding Disorders","enrollment":1126},{"nctId":"NCT05499832","phase":"PHASE3","title":"Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-03-21","conditions":"Ischemic Stroke","enrollment":156},{"nctId":"NCT07400848","phase":"","title":"Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome","status":"RECRUITING","sponsor":"University of Bern","startDate":"2026-02-15","conditions":"Post-Acute COVID-19 Vaccination Syndrome, Postviral Fatigue","enrollment":200},{"nctId":"NCT02557451","phase":"NA","title":"Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2016-04-28","conditions":"Subretinal Haematoma Linked to AMD","enrollment":91},{"nctId":"NCT04663750","phase":"PHASE3","title":"Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).","status":"RECRUITING","sponsor":"King's College Hospital NHS Trust","startDate":"2021-04-16","conditions":"Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage","enrollment":210},{"nctId":"NCT07111559","phase":"PHASE4","title":"Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial","status":"RECRUITING","sponsor":"Nippon Medical School","startDate":"2025-08-01","conditions":"Lacunar Stroke, Stroke, Ischemic Stroke","enrollment":500},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT07360717","phase":"NA","title":"To Compare the Efficacy & Safety of Ultra-Slow (24 hr) Low Dose (25 mg) Infusion of Alteplase Over Slow (24hr) Infusion of Streptokinase in Mechanical Prosthetic Valve Thrombosis","status":"COMPLETED","sponsor":"U. N. Mehta Institute of Cardiology and Research Center","startDate":"2024-11-01","conditions":"Thrombolysed","enrollment":100},{"nctId":"NCT06658197","phase":"PHASE3","title":"Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-25","conditions":"Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain","enrollment":850},{"nctId":"NCT07360509","phase":"NA","title":"Evaluation of Treatment Outcomes With Palatal Plate Versus Conventional Tooth Borne Anchorage in Class III Patients","status":"COMPLETED","sponsor":"Faculty of Dental Medicine for Girls","startDate":"2023-08-15","conditions":"Skeletal Class III Malocclusion","enrollment":14},{"nctId":"NCT06310018","phase":"","title":"Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE","status":"SUSPENDED","sponsor":"Brigham and Women's Hospital","startDate":"2027-01-01","conditions":"Pulmonary Embolism, Right Ventricular Dysfunction, Right Ventricular Failure","enrollment":60},{"nctId":"NCT07302854","phase":"PHASE2, PHASE3","title":"Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion","status":"RECRUITING","sponsor":"Xiang Luo","startDate":"2025-12-30","conditions":"Acute Ischemic Stroke, Medium Vessel Occlusion","enrollment":382},{"nctId":"NCT07003646","phase":"","title":"Reperfusion Treatment in Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Sahlgrenska University Hospital","startDate":"2025-04-01","conditions":"Pulmonary Embolism","enrollment":220},{"nctId":"NCT06949228","phase":"PHASE2, PHASE3","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial","status":"RECRUITING","sponsor":"ProMedica Health System","startDate":"2025-07-30","conditions":"Ischemic Stroke, Acute Disease","enrollment":132},{"nctId":"NCT07347626","phase":"PHASE3","title":"Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis","status":"NOT_YET_RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2026-03-01","conditions":"Acute Ischemic Stroke","enrollment":786},{"nctId":"NCT06887062","phase":"PHASE2","title":"Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2025-03-21","conditions":"Large Vessel Vasculitis, Giant Cell Arteritis (GCA), Takayasu Arteritis","enrollment":60},{"nctId":"NCT07271342","phase":"","title":"Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-11-30","conditions":"Stroke","enrollment":10000},{"nctId":"NCT07318948","phase":"NA","title":"BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"NOT_YET_RECRUITING","sponsor":"Bo Wu","startDate":"2026-01-01","conditions":"Acute Ischemic Stroke","enrollment":1600},{"nctId":"NCT00412867","phase":"PHASE4","title":"Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2006-12","conditions":"Stroke","enrollment":58},{"nctId":"NCT05766124","phase":"PHASE2, PHASE3","title":"Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-11-01","conditions":"Pleural Infection","enrollment":30},{"nctId":"NCT00147316","phase":"PHASE3","title":"Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2002-04","conditions":"Cerebral Infarction, Brain Ischemia","enrollment":103},{"nctId":"NCT06987305","phase":"PHASE3","title":"Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window","status":"RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2025-10-21","conditions":"Stroke, Acute Ischemic","enrollment":820},{"nctId":"NCT06210633","phase":"","title":"Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke","status":"RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-01-20","conditions":"Acute Ischemic Stroke (AIS), Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":1000},{"nctId":"NCT04434768","phase":"PHASE1","title":"Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ever Supreme Bio Technology Co., Ltd.","startDate":"2020-12-02","conditions":"Acute Stroke","enrollment":10},{"nctId":"NCT05728333","phase":"PHASE2, PHASE3","title":"Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke","status":"RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2023-11-28","conditions":"Stroke, Acute Ischemic","enrollment":800},{"nctId":"NCT06184321","phase":"EARLY_PHASE1","title":"Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-08-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":30},{"nctId":"NCT07092709","phase":"PHASE3","title":"Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-08-14","conditions":"Acute Ischemic Stroke","enrollment":912},{"nctId":"NCT07201688","phase":"PHASE3","title":"Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.","status":"RECRUITING","sponsor":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2025-11-30","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT05752916","phase":"PHASE4","title":"Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-06-02","conditions":"Acute Ischemic Stroke","enrollment":570},{"nctId":"NCT07208097","phase":"NA","title":"Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-10-25","conditions":"Intracerebral Haemorrhage, Minimally Invasive Treatment","enrollment":768},{"nctId":"NCT05363397","phase":"PHASE2","title":"Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke","status":"RECRUITING","sponsor":"The Florey Institute of Neuroscience and Mental Health","startDate":"2023-09-27","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT06221371","phase":"PHASE3","title":"Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-25","conditions":"Ischemic Stroke, Acute, Thrombolysis, Endovascular Treatment","enrollment":391},{"nctId":"NCT06196320","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-24","conditions":"Ischemic Stroke, Acute","enrollment":452},{"nctId":"NCT05631847","phase":"NA","title":"Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke","status":"COMPLETED","sponsor":"Sichuan Academy of Medical Sciences","startDate":"2023-04-17","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis","enrollment":345},{"nctId":"NCT07227740","phase":"","title":"Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury","status":"RECRUITING","sponsor":"Craig Hospital","startDate":"2025-07-15","conditions":"Spinal Cord Injuries, Endothelial Dysfunction, Testosterone Deficiency","enrollment":48},{"nctId":"NCT05573659","phase":"NA","title":"Capillary Refill Time Calculated With a Video-assisted Method Has a Better Reproducibility Than Visual Method in Critically Ill Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2022-10-06","conditions":"Intensive Care Unit, Mortality, Reliability","enrollment":59},{"nctId":"NCT07047014","phase":"PHASE3","title":"Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-30","conditions":"Stroke, Ischemic, Medium Vessel Occlusions","enrollment":596},{"nctId":"NCT06954155","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-05-30","conditions":"Stroke","enrollment":330},{"nctId":"NCT07162363","phase":"PHASE2, PHASE3","title":"Synergistic Minimally Invasive Surgery and Deferoxamine in ICH","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2026-03-01","conditions":"Intracerebral Hemorrhage, ICH - Intracerebral Hemorrhage","enrollment":240},{"nctId":"NCT04095676","phase":"NA","title":"VATS Surgery Compared to Drainage in the Treatment of Pleural Empyema","status":"RECRUITING","sponsor":"Thomas Decker Christensen","startDate":"2022-10-30","conditions":"Pleural Empyema","enrollment":184},{"nctId":"NCT04526951","phase":"PHASE3","title":"TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2020-10-30","conditions":"Central Retinal Artery Occlusion","enrollment":81},{"nctId":"NCT03335839","phase":"PHASE3","title":"Adjunctive, Low-dose tPA in Primary PCI for STEMI","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2018-04-01","conditions":"Myocardial Infarction, Percutaneous Coronary Intervention","enrollment":210},{"nctId":"NCT07185022","phase":"NA","title":"Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion","status":"NOT_YET_RECRUITING","sponsor":"The Second Hospital of Anhui Medical University","startDate":"2025-10-01","conditions":"Stroke, Cerebrovascular Disorders, Brain Diseases","enrollment":282},{"nctId":"NCT06320431","phase":"PHASE3","title":"ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2024-09-26","conditions":"Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic","enrollment":4000},{"nctId":"NCT05797792","phase":"PHASE3","title":"CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-11-18","conditions":"Stroke, Acute Ischemic, Stroke, Acute","enrollment":440},{"nctId":"NCT07168278","phase":"PHASE3","title":"Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-11-01","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase","enrollment":794},{"nctId":"NCT07095361","phase":"PHASE4","title":"Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-09","conditions":"Pleural Infection Bacterial, Pleural Infections, Pleural Infections and Inflammations","enrollment":270},{"nctId":"NCT06337175","phase":"PHASE4","title":"Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2021-06-01","conditions":"Ischemic Stroke, Alteplase Adverse Reaction","enrollment":600},{"nctId":"NCT04218773","phase":"EARLY_PHASE1","title":"Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study","status":"SUSPENDED","sponsor":"Yale University","startDate":"2020-09-11","conditions":"Ischemic Stroke, Blood Pressure","enrollment":40},{"nctId":"NCT06347107","phase":"NA","title":"Robotic Subretinal tPA Injection Study","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2024-06-21","conditions":"Subretinal Hemorrhage, Age-Related Macular Degeneration","enrollment":20},{"nctId":"NCT06878066","phase":"PHASE3","title":"Thrombolysis in Factor Xa-inhibitors Trial","status":"RECRUITING","sponsor":"Guri Hagberg","startDate":"2025-03-14","conditions":"Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke","enrollment":300},{"nctId":"NCT07146360","phase":"PHASE3","title":"Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2014-05-25","conditions":"Myocardial Infarction (MI)","enrollment":180},{"nctId":"NCT05630612","phase":"PHASE2","title":"ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Edinburgh","startDate":"2022-12-08","conditions":"ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases","enrollment":32},{"nctId":"NCT06010628","phase":"PHASE4","title":"Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2024-02-01","conditions":"Stroke, Ischemic","enrollment":1440},{"nctId":"NCT02315898","phase":"PHASE2","title":"Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2018-03-19","conditions":"Plastic Bronchitis, Protein-Losing Enteropathies, Healthy","enrollment":40},{"nctId":"NCT07073469","phase":"PHASE3","title":"Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Stroke Ischemic","enrollment":330},{"nctId":"NCT05897554","phase":"NA","title":"Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation (IAT-TOP)","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-08-11","conditions":"Acute Ischemic Stroke, Arterial Thrombosis, Posterior Circulation Brain Infarction","enrollment":247},{"nctId":"NCT07119021","phase":"PHASE4","title":"Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)","status":"RECRUITING","sponsor":"Ruijun Ji","startDate":"2024-08-01","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT04356833","phase":"PHASE2","title":"Nebulised Rt-PA for ARDS Due to COVID-19","status":"COMPLETED","sponsor":"University College, London","startDate":"2020-04-22","conditions":"COVID","enrollment":35},{"nctId":"NCT07098676","phase":"","title":"Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Ai Peng","startDate":"2024-11-20","conditions":"Healthy Individuals (Controls), Vascular Surgery Patients With Acute Thrombosis, Dialysis Patients","enrollment":900},{"nctId":"NCT03187405","phase":"PHASE3","title":"Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage.","status":"TERMINATED","sponsor":"University Hospital, Caen","startDate":"2018-02-21","conditions":"Subarachnoid Hemorrhage","enrollment":81},{"nctId":"NCT04920448","phase":"PHASE2","title":"N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE","status":"TERMINATED","sponsor":"University Hospital, Caen","startDate":"2021-06-16","conditions":"Stroke, Ischemic","enrollment":12},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT05657457","phase":"PHASE3","title":"Improving Neurological Outcome for Acute Basilar Artery Occlusion With Sufficient Recanalization After Thrombectomy by Intraarterial Tenecteplase (INSIST-IT)","status":"TERMINATED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-03-21","conditions":"Stroke, Ischemic","enrollment":145},{"nctId":"NCT05657470","phase":"PHASE2, PHASE3","title":"Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK)","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-03-21","conditions":"Stroke, Ischemic","enrollment":80},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT04806373","phase":"PHASE4","title":"Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis","status":"COMPLETED","sponsor":"Memorial Healthcare System","startDate":"2021-06-15","conditions":"Pleural Effusion","enrollment":27},{"nctId":"NCT06801054","phase":"PHASE1","title":"Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose","status":"NOT_YET_RECRUITING","sponsor":"Memorial Hermann Health System","startDate":"2025-07-01","conditions":"Acute Ischemic Stroke","enrollment":20},{"nctId":"NCT06768138","phase":"PHASE3","title":"Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke","status":"RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-06-01","conditions":"Stroke, Acute Ischemic","enrollment":626},{"nctId":"NCT06713382","phase":"PHASE2","title":"Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections [LYTICS +]","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-04-10","conditions":"Pleural Effusion Associated With Pulmonary Infection, Pleural Effusion Disorder, Pleural Effusions","enrollment":96},{"nctId":"NCT06187987","phase":"","title":"Mechanical Thrombectomy With the FlowTriever Device in Acute Pulmonary Embolism - a Retrospective Analysis","status":"COMPLETED","sponsor":"Kristina Svennerholm","startDate":"2023-04-01","conditions":"Pulmonary Embolism","enrollment":132},{"nctId":"NCT04430569","phase":"PHASE3","title":"Pulmonary Embolism International THrOmbolysis Study-3","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-08-04","conditions":"Pulmonary Embolism","enrollment":800},{"nctId":"NCT06769256","phase":"PHASE4","title":"Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2025-01-01","conditions":"ST-segment Elevation Myocardial Infarction (STEMI)","enrollment":300},{"nctId":"NCT04965038","phase":"PHASE3","title":"Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2022-10-10","conditions":"Central Retinal Artery Occlusion","enrollment":422}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"HAEMORRHAGE INTRACRANIAL"},{"count":7,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":7,"reaction":"FATIGUE"},{"count":7,"reaction":"HYPOTENSION"},{"count":7,"reaction":"NAUSEA"},{"count":7,"reaction":"TACHYCARDIA"},{"count":6,"reaction":"DIZZINESS"},{"count":6,"reaction":"DYSPNOEA"},{"count":6,"reaction":"PULMONARY EMBOLISM"},{"count":5,"reaction":"ANAEMIA"}],"_approvalHistory":[],"publicationCount":32346,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tissue plasminogen activator","tissue plasminogen activator","alteplase","Actilyse®","Activase"],"phase":"marketed","status":"active","brandName":"tPA","genericName":"tPA","companyName":"Life Recovery Systems","companyId":"life-recovery-systems","modality":"Small molecule","firstApprovalDate":"","aiSummary":"tPA (tissue plasminogen activator) converts plasminogen to plasmin, which breaks down fibrin clots to restore blood flow. Used for Acute ischemic stroke (within 4.5 hours of symptom onset), Acute myocardial infarction, Pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}